Intranasal and inhaled corticosteroids in allergic rhinitis and asthma

D. K. C. Lee (Ipswich, United Kingdom)

Source: Annual Congress 2004 - Therapy in asthma and COPD
Session: Therapy in asthma and COPD
Session type: Thematic Poster Session
Number: 883
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. K. C. Lee (Ipswich, United Kingdom). Intranasal and inhaled corticosteroids in allergic rhinitis and asthma. Eur Respir J 2004; 24: Suppl. 48, 883

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

Does treatment of allergic rhinitis with intranasal steroids improve asthma control
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008


Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 663s
Year: 2006

Budesonide nasal spray alone or in combination with cetirizine in patients with severe seasonal allergic rhinitis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 45s
Year: 2002

Effect of adding montelukast on asthma and rhinitis in asthma patients with concomitant allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 121s
Year: 2006

Budesonide and loratadine in the treatment of allergic rhinitis in children
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003

The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab
Source: Eur Respir J 2003; 22: Suppl. 45, 203s
Year: 2003

Persistent airway inflammation in young allergic wheezing children treated with inhaled corticosteroids
Source: Annual Congress 2003 - Current issues on wheezing in infancy
Year: 2003


Levocetirizine and montelukast in the treatment of seasonal allergic rhinitis
Source: Eur Respir J 2005; 26: Suppl. 49, 137s
Year: 2005

Is montelukast effective in allergic rhinitis in children?
Source: Eur Respir J 2006; 28: Suppl. 50, 263s
Year: 2006

Impact of allergic rhinitis on asthma
Source: Annual Congress 2012 - PG6 Hot topics in paediatric allergy
Year: 2012



Specific allergen immunotherapy of asthma combined with allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006

Inhaled corticosteroids attenuate experimental allergic rhinitis related cough in guinea pigs
Source: Eur Respir J 2006; 28: Suppl. 50, 220s
Year: 2006

Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

Systemic steroid use in children with allergic (IgE-mediated) asthma receiving omalizumab
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010

Sublingual monomeric allergoid immunotherapy improves airway inflammation, airway hyperresponsiveness and clinical symptoms in allergic rhinitis and asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 439s
Year: 2006

The role of omalizumab or rhuMAb-E25 in the treatment of allergic rhinitis
Source: Eur Respir J 2004; 24: 330
Year: 2004


Effect of desloratadine on patients suffer from allergic rhinitis and bronchial hyperreactivity
Source: Eur Respir J 2003; 22: Suppl. 45, 135s
Year: 2003